Ryman Healthcare Limited Stock Debt To Equity

RH7 Stock  EUR 2.21  0.02  0.91%   
Ryman Healthcare Limited fundamentals help investors to digest information that contributes to Ryman Healthcare's financial success or failures. It also enables traders to predict the movement of Ryman Stock. The fundamental analysis module provides a way to measure Ryman Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ryman Healthcare stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ryman Healthcare Limited Company Debt To Equity Analysis

Ryman Healthcare's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

 = 

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Ryman Healthcare Debt To Equity

    
  61.60 %  
Most of Ryman Healthcare's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ryman Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Competition

According to the company disclosure, Ryman Healthcare Limited has a Debt To Equity of 61%. This is 15.05% higher than that of the Healthcare sector and 61.43% lower than that of the Long-Term Care Facilities industry. The debt to equity for all Germany stocks is 26.49% lower than that of the firm.

Ryman Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ryman Healthcare's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ryman Healthcare could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics of similar companies.
Ryman Healthcare is currently under evaluation in debt to equity category among related companies.

Ryman Fundamentals

About Ryman Healthcare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryman Healthcare Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Ryman Stock analysis

When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Please note, there is a significant difference between Ryman Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryman Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryman Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.